About QuidelOrtho Corporation 
QuidelOrtho Corporation (Nasdaq: QDEL) is a global leader in in vitro diagnostics, providing fast, accurate and reliable solutions across clinical chemistry, immunoassay, molecular diagnostics and transfusion medicine.
Our technologies support informed decision-making from the emergency department and point of care to the central laboratory. By combining scientific expertise with practical innovation, we help healthcare professionals respond confidently in both routine and acute care environments.
Building on a strong legacy of innovation, QuidelOrtho partners with healthcare providers worldwide to advance diagnostics that improve patient outcomes and support a more efficient healthcare system.